Cargando…
High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia
Acute myeloid leukemia (AML) is a frequent malignancy in adults worldwide; identifying preferable biomarkers has become one of the current challenges. Given that COMMD7 has been reported associated with tumor progression in various human solid cancers but rarely reported in AML, herein, RNA sequenci...
Autores principales: | Li, Kongfei, Chen, Lieguang, Zhang, Hua, Wang, Lu, Sha, Keya, Du, Xiaohong, Li, Daiyang, Zheng, Zhongzheng, Pei, Renzhi, Lu, Ying, Tong, Hongyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109082/ https://www.ncbi.nlm.nih.gov/pubmed/33891561 http://dx.doi.org/10.18632/aging.202901 |
Ejemplares similares
-
Comprehensive characterization of driver genes in diffuse large B cell lymphoma
por: Fan, Zheng, et al.
Publicado: (2020) -
ZNF460-regulated COMMD7 Promotes Acute Myeloid Leukemia Proliferation Via the NF-κB Signaling Pathway
por: Shao, Xin, et al.
Publicado: (2023) -
Comprehensive analysis of COMMD10 as a novel prognostic biomarker for gastric cancer
por: Zhao, Wenfang, et al.
Publicado: (2023) -
ShRNA-Targeted COMMD7 Suppresses Hepatocellular Carcinoma Growth
por: Zheng, Lu, et al.
Publicado: (2012) -
Correction: ShRNA-Targeted COMMD7 Suppresses Hepatocellular Carcinoma Growth
por: Zheng, Lu, et al.
Publicado: (2019)